Ontario Genomics announced its investment in Ardra Inc. via its Pre-Commercial Business Development Fund earlier this week. Ardra, which developed out of postdoctoral research in the Department of Chemical Engineering & Applied Chemistry under the supervision of Professor Krishna Mahadevan, is a specialty chemicals company focused on the production of natural ingredients for the cosmetics and flavour and fragrance industries.
The $100,000 investment from Ontario Genomics will advance the development of natural leaf aldehyde, a green leaf volatile used in green apple flavour, and as a scent in perfumery. The CEO Dr. Pratish Gawand commented: “We are thrilled to receive the funding from Ontario Genomics. It de-risks and supports the commercialization of Ardra’s process for natural leaf-aldehyde. The funding will help us establish a working process for the flavour ingredient as we continue to further develop our product pipeline.”
Read the full story HERE